Dehaier Earns A- Credit Rating Zhongguancun Enterprises Credit Promotion Association
January 28 2014 - 8:00AM
Dehaier Medical Systems Ltd. (Nasdaq:DHRM)
("Dehaier" or the "Company"), an emerging leader in the
development, assembly, marketing and sale of medical devices and
homecare medical products in China, today announced that the
Beijing Zhongguancun Enterprises Credit Promotion Association has
awarded Dehaier an A- credit rating. This new rating is effective
from December 16, 2013 through December 15, 2014.
Mr. Ping Chen, Chairman and Chief Executive Officer of Dehaier
Medical stated, "Dehaier's well-established financial profile,
including healthy financial statements, steady cash flow, timely
payment and low credit risk, contributed to our favorable rating.
This is our second consecutive year receiving the A- credit rating
from a well-known rating association in Beijing, a testament to our
operations, controls and management. We are confident that focusing
on our core business strategies and operating with integrity to
validate our credit rating will benefit our company and
shareholders over the long term."
About Dehaier Medical Systems Ltd.
Dehaier is an emerging leader in the development, assembly,
marketing and sale of medical products, including respiratory and
oxygen homecare medical products. The company develops and
assembles its own branded medical devices and homecare medical
products from third-party components. The company also distributes
products designed and manufactured by other companies, including
medical devices from IMD (Italy), Welch Allyn (USA), HEYER
(Germany), Timesco (UK), eVent Medical (US) and JMS (Japan).
Dehaier's technology is based on six patents, ten software
copyrights and proprietary technology. More information may be
found at http://www.dehaier.com.cn
Forward-looking Statements
This news release contains forward-looking
statements as defined by the Private Securities Litigation Reform
Act of 1995. Forward-looking statements include statements
concerning plans, objectives, goals, strategies, future events,
government approvals or performance, and underlying assumptions and
other statements that are other than statements of historical
facts, including in particular any implications regarding the
implications, if any, of the credit rating described in this press
release. These statements are subject to uncertainties and risks
including, but not limited to, product and service demand and
acceptance, fulfillment of bids and contracts, changes in
technology, economic conditions, the impact of competition and
pricing, government regulation, and other risks contained in
reports filed by the company with the Securities and Exchange
Commission. All such forward-looking statements, whether written or
oral, and whether made by or on behalf of the company, are
expressly qualified by the cautionary statements and any other
cautionary statements which may accompany the forward-looking
statements. In addition, the company disclaims any obligation to
update any forward-looking statements to reflect events or
circumstances after the date hereof.
CONTACT: Dehaier Medical Systems Limited
Surie Liu
+86 10-5166-0080
lius@dehaier.com.cn
Dehaier Medical Systems Limited
Tina He
+86 10-5166-0080
hexw@dehaier.com.cn
Lianluo Smart (NASDAQ:LLIT)
Historical Stock Chart
From Sep 2024 to Oct 2024
Lianluo Smart (NASDAQ:LLIT)
Historical Stock Chart
From Oct 2023 to Oct 2024